We are live on
!
Find out more
CG
Cutler Group Portfolio holdings
AUM
$307M
1-Year Est. Return
45.11%
This Fund
S&P 500
This Quarter
Est. Return
+7.53%
1 Year Est. Return
+45.11%
3 Year Est. Return
+57.72%
5 Year Est. Return
+302.49%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$307M
(+13%)
Cap. Flow
+$2.8B
Cap. Flow
% of AUM
103.22%
Top 10 Holdings %
Top 10 Hldgs %
23.01%
Holding
7,805
New
1,401
Increased
2,380
Reduced
2,248
Closed
1,408
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$125M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$85.9M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$31.6M |
| 4 |
NVIDIA
NVDA
|
+$29M |
| 5 |
Biogen
BIIB
|
+$23.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$79.3M |
| 2 |
Apple
AAPL
|
+$77.9M |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$47.1M |
| 4 |
CEO
CNOOC Limited
CEO
|
+$17.6M |
| 5 |
Meta Platforms (Facebook)
META
|
+$17.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 10.94% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 6.66% |
| 4 | Communication Services | 6.39% |
| 5 | Financials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
2051
PUT
DELISTED
Celgene Corp
CELG
| $81K | ﹤0.01% |
26,400
+19,800
| +300% | +$2.43M |
|
|
CYS
2052
DELISTED
CYS Investments Inc.
CYS
| $81K | ﹤0.01% |
+9,721
| New | +$81.7K |
|
2053
Barings BDC
BBDC
$885M
| $80K | ﹤0.01% |
4,587
-6,338
| -58% | -$115K |
|
2054
Cameco
CCJ
$37.9B
| $80K | ﹤0.01% |
8,807
-14,492
| -62% | -$144K |
|
2055
CALL
Kroger
KR
$36.3B
| $80K | ﹤0.01% |
164,300
+112,500
| +217% | +$3.19M |
|
2056
CALL
Marathon Petroleum
MPC
$89.3B
| $80K | ﹤0.01% |
65,300
-74,700
| -53% | -$3.86M |
|
2057
PUT
Qorvo
QRVO
$8.09B
| $80K | ﹤0.01% |
24,800
+6,500
| +36% | +$465K |
|
2058
PUT
TherapeuticsMD
TXMD
$23.8M
| $80K | ﹤0.01% |
344
-748
| -68% | -$187K |
|
|
VRN
2059
DELISTED
Veren
VRN
| $80K | ﹤0.01% |
10,551
-1,153
| -10% | -$10.8K |
|
|
QADB
2060
DELISTED
QAD Inc. Class B
QADB
| $80K | ﹤0.01% |
2,984
+1,219
| +69% | +$31.7K |
|
|
SINA
2061
CALL
DELISTED
Sina Corp
SINA
| $80K | ﹤0.01% |
12,100
+10,800
| +831% | +$910K |
|
2062
Sunoco
SUN
$14.4B
| $79K | ﹤0.01% |
2,593
-13,697
| -84% | -$409K |
|
2063
Standex International
SXI
$3.56B
| $79K | ﹤0.01% |
+878
| New | +$79.7K |
|
2064
PUT
Molson Coors Class B
TAP
$7.97B
| $79K | ﹤0.01% |
39,900
+34,600
| +653% | +$3.21M |
|
2065
PUT
Teekay
TK
$981M
| $79K | ﹤0.01% |
27,500
-8,900
| -24% | -$65.7K |
|
2066
CALL
Ubiquiti
UI
$32.4B
| $79K | ﹤0.01% |
20,900
+11,700
| +127% | +$579K |
|
2067
Veeco
VECO
$2.79B
| $79K | ﹤0.01% |
+2,866
| New | +$88.1K |
|
|
ONCE
2068
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $79K | ﹤0.01% |
14,900
-2,900
| -16% | -$162K |
|
|
SGG
2069
DELISTED
iPath Bloomberg Sugar Subindex Total Return ETN due June 24, 2038
SGG
| $79K | ﹤0.01% |
2,753
+2,500
| +988% | +$81.9K |
|
2070
PUT
ProShares Ultra NASDAQ Biotechnology
BIB
$84.4M
| $78K | ﹤0.01% |
19,400
-3,100
| -14% | -$151K |
|
2071
Cogent Communications
CCOI
$649M
| $78K | ﹤0.01% |
1,970
+664
| +51% | +$27.5K |
|
2072
Compass Diversified
CODI
$777M
| $78K | ﹤0.01% |
4,500
-764
| -15% | -$12.7K |
|
2073
PUT
Capital One
COF
$130B
| $78K | ﹤0.01% |
48,400
+41,300
| +582% | +$3.36M |
|
2074
CALL
iShares MSCI Europe Financials ETF
EUFN
$4.05B
| $78K | ﹤0.01% |
101,000
+94,000
| +1,343% | +$2.01M |
|
|
GES
2075
DELISTED
Guess Inc
GES
| $78K | ﹤0.01% |
6,137
+4,342
| +242% | +$48.8K |
|
Similar funds
MFF
HCM
CSC
ORPU
SFG
RG
FW
APWM
Cutler Group's Q2 2017 Portfolio in Review
As of Q2 2017, Cutler Group held 7,805 positions worth $2.71B, up 13% from $2.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Cutler Group deployed $2.8B of net new capital in Q2 2017, opening 1,401 new positions and adding to 2,380 existing holdings. Its largest new stake was iShares US Medical Devices ETF: 316,230 shares worth $8.78M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, up from 6.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $77.9M trimmed.
- Cutler Group's largest Q2 2017 buy was iShares US Medical Devices ETF: 316,230 shares worth $8.78M.
- Cutler Group added most to Amazon in Q2 2017, an estimated $125M increase.
- Cutler Group's biggest Q2 2017 reduction was Apple, cutting an estimated $77.9M.
- Cutler Group fully exited Invesco QQQ Trust in Q2 2017, selling an estimated $79.3M.
- Cutler Group's ten largest holdings make up 23% of its $2.71B portfolio in Q2 2017.
- Cutler Group opened 1,401 new positions and closed 1,408 in Q2 2017.
- Cutler Group's portfolio value rose 13% quarter-over-quarter to $2.71B.
Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.